Check-Cap (CHEK) Reports Q1 Loss of $0.53/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Check-Cap Reports First Quarter 2015 Financial Results and Provides Corporate Update
June 4, 2015 9:15 AM EDTISFIYA, Israel, June 4, 2015 /PRNewswire/ --Â Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ:Â CHEK, CHEKW), a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening, today provided a corporate update and announced financial results for the first quarter, ended March 31, 2015.
"In recent months, Check-Cap has made significant progress advancing our corporate and clinical objectives," said Guy Neev, CEO of Check-Cap. "Following our IPO in February, we received a critical Notice of Allowance from the U.S. Patent and Trademark Office, further strengthening our global intellectual property position. In... More
